Warren E. Ross
Impact in
- Toxicology top 0.1%
- Bioactive Compounds and Antitumor Agents
- Oncology top 2%
- Lung Cancer Research Studies
- Drug Transport and Resistance Mechanisms
Papers in
-
- Cancer therapeutics and mechanisms 41
- DNA and Nucleic Acid Chemistry 11
- Plant-derived Lignans Synthesis and Bioactivity 9
- DNA Repair Mechanisms 7
-
- Bioactive Compounds and Antitumor Agents 7
- Co-authors
- Bonnie S. Glisson (10 shared papers)Kurt W. Kohn (7 shared papers)Richard B. Lock (6 shared papers)Daniel L. Glaubiger (3 shared papers)Jack C. Yalowich (4 shared papers)Kuan‐Chih Chow (5 shared papers)Daniel M. Sullivan (6 shared papers)Antoinette J. Wozniak (2 shared papers)
- Journals
- Biochemical Pharmacology (6 papers)Cancer (4 papers)Molecular and Cellular Biology (4 papers)Molecular Pharmacology (2 papers)Biochemistry (2 papers)
- Partner nations
- United StatesCanada
In The Last Decade
Warren E. Ross
56 papers receiving 3.9k citations
Warren E. Ross's Hit Papers
Peers
Comparison fields: 5 of 120
- Toxicology 576
- Oncology 1.7k
- Molecular Biology 3.4k
- Cancer Research 378
- Organic Chemistry 694
Countries citing papers authored by Warren E. Ross
This map shows the geographic impact of Warren E. Ross's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Warren E. Ross with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Warren E. Ross more than expected).
Fields of papers citing papers by Warren E. Ross
This network shows the impact of papers produced by Warren E. Ross. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Warren E. Ross. The network helps show where Warren E. Ross may publish in the future.
Co-authors
The 25 scholars most cited alongside Warren E. Ross, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 56 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Role of topoisomerase II in mediating epipodophyllotoxin-induced DNA cleavage. Hit paper breakdown → | 1984 | 426 |
| 2 | 1979 | 231 | |
| 3 | 1978 | 228 | |
| 4 | Inhibition of p34cdc2 kinase activity by etoposide or irradiation as a mechanism of G2 arrest in Chinese hamster ovary cells. | 1990 | 208 |
| 5 | DNA damage as a basis for 4'-demethylepipodophyllotoxin-9-(4,6-O-ethylidene-beta-D-glucopyranoside) (etoposide) cytotoxicity. | 1983 | 204 |
| 6 | 1985 | 184 | |
| 7 | 1986 | 163 | |
| 8 | Characterization of acquired epipodophyllotoxin resistance in a Chinese hamster ovary cell line: loss of drug-stimulated DNA cleavage activity. | 1986 | 154 |
| 9 | 1981 | 149 | |
| 10 | Proliferation-dependent topoisomerase II content as a determinant of antineoplastic drug action in human, mouse, and Chinese hamster ovary cells. | 1987 | 139 |
| 11 | Differences between melphalan and nitrogen mustard in the formation and removal of DNA cross-links. | 1978 | 137 |
| 12 | 1987 | 135 | |
| 13 | 1987 | 128 | |
| 14 | 1983 | 119 | |
| 15 | Camptothecin-resistant mutants of Chinese hamster ovary cells containing a resistant form of topoisomerase I. | 1988 | 116 |
| 16 | Kinetics of formation and disappearance of a DNA cross-linking effect in mouse leukemia L1210 cells treated with cis- and trans-diamminedichloroplatinum(II). | 1978 | 106 |
| 17 | 1985 | 98 | |
| 18 | 1988 | 97 | |
| 19 | Cross-resistance to intercalating agents in an epipodophyllotoxin-resistant Chinese hamster ovary cell line: evidence for a common intracellular target. | 1986 | 88 |
| 20 | Possible role for p34cdc2 kinase in etoposide-induced cell death of Chinese hamster ovary cells. | 1990 | 85 |
About Warren E. Ross
Warren E. Ross is a scholar working on Molecular Biology, Toxicology, Oncology, Organic Chemistry and Neurology, having authored 56 papers that have together received 4.2k indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (41 papers), DNA and Nucleic Acid Chemistry (11 papers), Plant-derived Lignans Synthesis and Bioactivity (9 papers), Synthesis and Biological Evaluation (9 papers), DNA Repair Mechanisms (7 papers), Bioactive Compounds and Antitumor Agents (7 papers), Lung Cancer Research Studies (5 papers) and Neuroblastoma Research and Treatments (4 papers). The work is most often cited by research in Toxicology (576 citations), Oncology (1.7k citations), Molecular Biology (3.4k citations), Cancer Research (378 citations) and Organic Chemistry (694 citations). Warren E. Ross has collaborated with scholars based in United States and Canada. Frequent co-authors include Bonnie S. Glisson, Kurt W. Kohn, Richard B. Lock, Daniel L. Glaubiger, Jack C. Yalowich, Kuan‐Chih Chow, Daniel M. Sullivan, Antoinette J. Wozniak, Leroy F. Liu and Matthews O. Bradley. Their work appears in journals such as Biochemical Pharmacology, Cancer, Molecular and Cellular Biology, Molecular Pharmacology and Biochemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.